Physician profile
John G Stoner
NPI 1225289408
$2,172.61
in general payments reported to CMS, 2019-2025
17 companies · $327 in 2025
The $327 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $705 · 2020: $414 · 2021: $58.48 · 2022: $37.31 · 2023: $186 · 2024: $445 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $958.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $958.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $432.39 | 2019-2025 | Skyrizi |
| Janssen Biotech, INC. | $309.53 | 2019-2024 | Tremfya, Simponi, Stelara |
| Sun Pharmaceutical Industries INC. | $229.41 | 2019-2025 | |
| Amgen INC. | $213.66 | 2020-2025 | Otezla, Otezla |
| Ucb, INC. | $133.43 | 2019-2025 | Bimzelx |
| Lilly USA, LLC | $131.10 | 2019-2023 | Olumiant, Taltz |
| Galderma Laboratories, L.P. | $116.62 | 2019-2025 | Nemluvio |
| Celgene Corporation | $96.54 | 2019 | |
| Leo Pharma INC. | $84.49 | 2021-2023 | Adbry |
| E.R. Squibb & Sons, L.L.C. | $80.81 | 2024-2025 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $80.78 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $79.75 | 2019-2025 | |
| Dermira, INC. | $50.60 | 2019-2020 | |
| Aclaris Therapeutics, INC. | $46.72 | 2019 | |
| Pfizer INC. | $31.99 | 2019-2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $29.96 | 2024 | Vtama |
| Strata Skin Sciences, INC. | $24.83 | 2019-2025 | Xtrac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Stoner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.